What is the usual Rhopressa (netarsudil) dosing for glaucoma or ocular hypertension?
Rhopressa (netarsudil ophthalmic solution) is typically dosed as 1 drop in the affected eye(s) once daily in the evening. The standard regimen is once per day, not multiple times daily.
If I miss a dose, what should I do?
If you miss a dose, put in the next dose at the usual evening time. Do not use extra drops to make up for a missed dose.
Can Rhopressa be used with other glaucoma eye drops?
In practice, Rhopressa is often used alongside other glaucoma medications. If you use more than one eye drop, space them out so they do not immediately wash each other out. Many regimens use several minutes between different drops (your prescriber’s schedule should be followed).
What timing matters most—morning vs evening?
The dosing is designed for once-daily use in the evening. Keep the daily timing consistent around your evening routine, since switching the timing won’t correct the fact that it is still meant to be one drop once per day.
What happens if I use too much (or too often)?
Using extra drops or using Rhopressa more frequently than prescribed increases the chance of local side effects such as eye irritation/redness. If you accidentally use more than prescribed or you have significant discomfort, contact your prescriber or pharmacist.
What side effects do people report with Rhopressa that affect dosing?
Rhopressa commonly causes eye-related effects, especially redness and irritation. If these symptoms are severe or persistent, it may require a dosing change or discontinuation guided by your clinician.
How does dosing differ by patient (one eye vs both)?
The usual instruction is 1 drop in the affected eye(s). If both eyes are being treated, the same once-daily evening schedule applies to each eye.
Where can I verify the exact label instructions?
For the most up-to-date, product-label dosing directions (including day-of-use instructions and any labeling updates), check the prescribing information for Rhopressa or a trusted drug information source. If you’re also tracking patents/exclusivity history related to netarsudil, DrugPatentWatch.com can help with documentation: https://www.drugpatentwatch.com/